Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Influence of forkhead box protein 3 polymorphisms (rs2232365, rs3761548) with the outcome of pregnancy: A meta-analysis.

Hosseini Teshnizi S, Ali-Hassanzadeh M, Gharesi-Fard B, Kabelitz D, Kalantar K.

J Cell Physiol. 2019 Feb 19. doi: 10.1002/jcp.28328. [Epub ahead of print]

PMID:
30784062
2.

Granulysin species segregate to different lysosome-related effector vesicles (LREV) and get mobilized by either classical or non-classical degranulation.

Lettau M, Dietz M, Dohmen K, Leippe M, Kabelitz D, Janssen O.

Mol Immunol. 2019 Mar;107:44-53. doi: 10.1016/j.molimm.2018.12.031. Epub 2019 Jan 16.

PMID:
30658247
3.

An update on immune dysregulation in obesity-related insulin resistance.

Daryabor G, Kabelitz D, Kalantar K.

Scand J Immunol. 2019 Apr;89(4):e12747. doi: 10.1111/sji.12747. Epub 2019 Jan 29. Review.

PMID:
30593678
4.

TGF-β enhances the cytotoxic activity of Vδ2 T cells.

Peters C, Meyer A, Kouakanou L, Feder J, Schricker T, Lettau M, Janssen O, Wesch D, Kabelitz D.

Oncoimmunology. 2018 Sep 26;8(1):e1522471. doi: 10.1080/2162402X.2018.1522471. eCollection 2019.

PMID:
30546961
5.

Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.

Mallon DH, Kling C, Robb M, Ellinghaus E, Bradley JA, Taylor CJ, Kabelitz D, Kosmoliaptsis V.

J Immunol. 2018 Dec 15;201(12):3780-3792. doi: 10.4049/jimmunol.1800683. Epub 2018 Nov 14.

6.

Preface.

Kabelitz D.

Recent Pat Antiinfect Drug Discov. 2018;13(1):2. doi: 10.2174/1574891X1301180927103705.

PMID:
30424718
7.

The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness.

Melandri D, Zlatareva I, Chaleil RAG, Dart RJ, Chancellor A, Nussbaumer O, Polyakova O, Roberts NA, Wesch D, Kabelitz D, Irving PM, John S, Mansour S, Bates PA, Vantourout P, Hayday AC.

Nat Immunol. 2018 Dec;19(12):1352-1365. doi: 10.1038/s41590-018-0253-5. Epub 2018 Nov 12.

PMID:
30420626
8.

DNA methylation profiling of hepatosplenic T-cell lymphoma.

Bergmann AK, Fataccioli V, Castellano G, Martin-Garcia N, Pelletier L, Ammerpohl O, Bergmann J, Bhat J, Pau ECS, Martín-Subero JI, Moffitt AB, Valencia A, Oberg HH, Wesch D, Jayne S, Dyer MJS, Kabelitz D, Gaulard P, Siebert R.

Haematologica. 2019 Mar;104(3):e104-e107. doi: 10.3324/haematol.2018.196196. Epub 2018 Oct 18. No abstract available.

9.

Correction to: Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions.

Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D.

Arch Gynecol Obstet. 2018 Oct;298(4):851. doi: 10.1007/s00404-018-4873-7.

10.

Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.

Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M, Paulsen M, Strigli A, Conrad C, Schuldt D, Sinha A, Ebsen H, Kornell SC, Nikolaus S, Arlt A, Kabelitz D, Ellrichmann M, Lützen U, Rosenstiel PC, Franke A, Schreiber S.

Gut. 2019 Jan;68(1):25-39. doi: 10.1136/gutjnl-2018-316023. Epub 2018 May 5.

PMID:
29730603
11.

Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.

Oberg HH, Kellner C, Gonnermann D, Sebens S, Bauerschlag D, Gramatzki M, Kabelitz D, Peipp M, Wesch D.

Front Immunol. 2018 Apr 19;9:814. doi: 10.3389/fimmu.2018.00814. eCollection 2018.

12.

Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?

Bhat J, Kouakanou L, Peters C, Yin Z, Kabelitz D.

Front Immunol. 2018 Mar 13;9:512. doi: 10.3389/fimmu.2018.00512. eCollection 2018. No abstract available.

13.

Regulatory functions of γδ T cells.

Peters C, Kabelitz D, Wesch D.

Cell Mol Life Sci. 2018 Jun;75(12):2125-2135. doi: 10.1007/s00018-018-2788-x. Epub 2018 Mar 8. Review.

PMID:
29520421
14.

Mechanistic peculiarities of activation-induced mobilization of cytotoxic effector proteins in human T cells.

Lettau M, Armbrust F, Dohmen K, Drews L, Poch T, Dietz M, Kabelitz D, Janssen O.

Int Immunol. 2018 Apr 25;30(5):215-228. doi: 10.1093/intimm/dxy007.

PMID:
29373679
15.

NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.

Flüh C, Chitadze G, Adamski V, Hattermann K, Synowitz M, Kabelitz D, Held-Feindt J.

Histochem Cell Biol. 2018 Mar;149(3):219-233. doi: 10.1007/s00418-018-1633-5. Epub 2018 Jan 22.

PMID:
29356965
16.

In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.

Chitadze G, Flüh C, Quabius ES, Freitag-Wolf S, Peters C, Lettau M, Bhat J, Wesch D, Oberg HH, Luecke S, Janssen O, Synowitz M, Held-Feindt J, Kabelitz D.

Oncoimmunology. 2017 Aug 8;6(11):e1358839. doi: 10.1080/2162402X.2017.1358839. eCollection 2017.

17.

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.

Klausz K, Cieker M, Kellner C, Oberg HH, Kabelitz D, Valerius T, Burger R, Gramatzki M, Peipp M.

Oncotarget. 2017 Sep 5;8(44):77552-77566. doi: 10.18632/oncotarget.20641. eCollection 2017 Sep 29.

18.

Fertility after recurrent miscarriages: results of an observational cohort study.

Kling C, Hedderich J, Kabelitz D.

Arch Gynecol Obstet. 2018 Jan;297(1):205-219. doi: 10.1007/s00404-017-4532-4. Epub 2017 Oct 16.

19.

Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.

Nagel I, Bartels M, Duell J, Oberg HH, Ussat S, Bruckmueller H, Ottmann O, Pfeifer H, Trautmann H, Gökbuget N, Caliebe A, Kabelitz D, Kneba M, Horst HA, Hoelzer D, Topp MS, Cascorbi I, Siebert R, Brüggemann M.

Blood. 2017 Nov 2;130(18):2027-2031. doi: 10.1182/blood-2017-05-782888. Epub 2017 Aug 21.

20.

Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity.

Bhat J, Helmuth J, Chitadze G, Kouakanou L, Peters C, Vingron M, Ammerpohl O, Kabelitz D.

Scand J Immunol. 2017 Oct;86(4):184-195. doi: 10.1111/sji.12589. Epub 2017 Sep 12. Review.

21.

Multilayer epigenetic analysis reveals novel transcription factor networks in CD8 T cells.

Bhat J, Kabelitz D.

Cell Mol Immunol. 2018 Mar;15(3):199-202. doi: 10.1038/cmi.2017.46. Epub 2017 Jul 31. No abstract available.

22.

The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.

Chitadze G, Oberg HH, Wesch D, Kabelitz D.

Trends Immunol. 2017 Sep;38(9):668-678. doi: 10.1016/j.it.2017.06.004. Epub 2017 Jul 11. Review.

PMID:
28709825
23.

CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.

Peipp M, Wesch D, Oberg HH, Lutz S, Muskulus A, van de Winkel JGJ, Parren PWHI, Burger R, Humpe A, Kabelitz D, Gramatzki M, Kellner C.

Scand J Immunol. 2017 Oct;86(4):196-206. doi: 10.1111/sji.12581.

24.

Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins.

Kabelitz D, Lettau M, Janssen O.

F1000Res. 2017 Jun 5;6. pii: F1000 Faculty Rev-782. doi: 10.12688/f1000research.11057.1. eCollection 2017. Review.

25.

The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.

Schneppenheim J, Loock AC, Hüttl S, Schweizer M, Lüllmann-Rauch R, Oberg HH, Arnold P, Lehmann CHK, Dudziak D, Kabelitz D, Lucius R, Lennon-Duménil AM, Saftig P, Schröder B.

J Immunol. 2017 Jul 1;199(1):172-185. doi: 10.4049/jimmunol.1601533. Epub 2017 May 26.

26.

TLR-induced immunomodulatory cytokine expression by human gingival stem/progenitor cells.

Mekhemar MK, Adam-Klages S, Kabelitz D, Dörfer CE, Fawzy El-Sayed KM.

Cell Immunol. 2018 Apr;326:60-67. doi: 10.1016/j.cellimm.2017.01.007. Epub 2017 Jan 10.

PMID:
28093098
27.

Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis.

Kerstein A, Schüler S, Cabral-Marques O, Fazio J, Häsler R, Müller A, Pitann S, Moosig F, Klapa S, Haas C, Kabelitz D, Riemekasten G, Wolters S, Lamprecht P.

J Autoimmun. 2017 Mar;78:79-91. doi: 10.1016/j.jaut.2016.12.004. Epub 2016 Dec 28.

28.

Human Vδ2 T cells are a major source of interleukin-9.

Peters C, Häsler R, Wesch D, Kabelitz D.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12520-12525. Epub 2016 Oct 17.

29.

Answer to the editor.

Kling C, Kabelitz D.

Arch Gynecol Obstet. 2017 Jan;295(1):259. doi: 10.1007/s00404-016-4210-y. Epub 2016 Oct 26. No abstract available.

PMID:
27785572
30.

Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.

Nerdal PT, Peters C, Oberg HH, Zlatev H, Lettau M, Quabius ES, Sousa S, Gonnermann D, Auriola S, Olive D, Määttä J, Janssen O, Kabelitz D.

J Immunol. 2016 Oct 15;197(8):3059-3068. Epub 2016 Sep 12.

31.

Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells.

Bhat J, Sosna J, Fritsch J, Quabius ES, Schütze S, Zeissig S, Ammerpohl O, Adam D, Kabelitz D.

Oncotarget. 2016 Oct 4;7(40):64743-64756. doi: 10.18632/oncotarget.11462.

32.

Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30years of γδ T cell research.

Kabelitz D.

Clin Immunol. 2016 Nov;172:90-97. doi: 10.1016/j.clim.2016.07.012. Epub 2016 Jul 18. No abstract available.

PMID:
27444042
33.

Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients.

Oberg HH, Grage-Griebenow E, Adam-Klages S, Jerg E, Peipp M, Kellner C, Petrick D, Gonnermann D, Freitag-Wolf S, Röcken C, Sebens T, Vogel I, Becker T, Ebsen M, Kabelitz D, Wesch D, Sebens S.

Pancreatology. 2016 Nov - Dec;16(6):1069-1079. doi: 10.1016/j.pan.2016.07.008. Epub 2016 Jul 11.

PMID:
27424476
34.

NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors.

Chitadze G, Lettau M, Luecke S, Wang T, Janssen O, Fürst D, Mytilineos J, Wesch D, Oberg HH, Held-Feindt J, Kabelitz D.

Oncoimmunology. 2015 Dec 10;5(4):e1093276. eCollection 2016 Apr.

35.

[Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides. German version].

Kerstein A, Müller A, Kabelitz D, Lamprecht P.

Z Rheumatol. 2016 Mar;75(2):183-6. doi: 10.1007/s00393-015-0025-7. German.

PMID:
26913718
36.

Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides.

Kerstein A, Müller A, Kabelitz D, Lamprecht P.

Z Rheumatol. 2017 Mar;76(Suppl 1):14-17. doi: 10.1007/s00393-016-0053-y.

PMID:
26913717
37.

Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history.

Kling C, Magez J, Hedderich J, von Otte S, Kabelitz D.

Arch Gynecol Obstet. 2016 May;293(5):1113-23. doi: 10.1007/s00404-015-4001-x. Epub 2016 Jan 21.

38.

TlR expression profile of human gingival margin-derived stem progenitor cells.

Fawzy-El-Sayed K, Mekhemar M, Adam-Klages S, Kabelitz D, Dörfer C.

Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21(1):e30-8.

39.

Erratum to: congenital HCMV and assisted reproduction: why not use the chance for primary screening?

Kling C, Kabelitz D.

Arch Gynecol Obstet. 2015 Dec;292(6):1401-2. doi: 10.1007/s00404-015-3888-6. No abstract available.

PMID:
26437954
40.

Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".

Kabelitz D, Déchanet-Merville J.

Front Immunol. 2015 Jul 21;6:371. doi: 10.3389/fimmu.2015.00371. eCollection 2015. No abstract available.

41.

Preface.

Kabelitz D.

Recent Pat Antiinfect Drug Discov. 2015;10(1):2. No abstract available.

PMID:
26203470
42.

Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.

Hüttl S, Kläsener K, Schweizer M, Schneppenheim J, Oberg HH, Kabelitz D, Reth M, Saftig P, Schröder B.

J Immunol. 2015 Aug 15;195(4):1548-63. doi: 10.4049/jimmunol.1403171. Epub 2015 Jul 8.

43.

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

Bhat J, Kabelitz D.

Oncoimmunology. 2015 Apr 28;4(6):e1006088. eCollection 2015 Jun.

44.

Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw.

Kalyan S, Wang J, Quabius ES, Huck J, Wiltfang J, Baines JF, Kabelitz D.

J Transl Med. 2015 Jul 4;13:212. doi: 10.1186/s12967-015-0568-z.

45.

Lysosome-Related Effector Vesicles in T Lymphocytes and NK Cells.

Lettau M, Kabelitz D, Janssen O.

Scand J Immunol. 2015 Sep;82(3):235-43. doi: 10.1111/sji.12337. Review.

46.

Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4⁺ T cells in granulomatosis with polyangiitis.

Schüler S, Wolters S, Pitann S, Kabelitz D, Lamprecht P.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-183-4. Epub 2015 May 26. No abstract available.

PMID:
26016770
47.

γδ T cell activation by bispecific antibodies.

Oberg HH, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, Kabelitz D, Wesch D.

Cell Immunol. 2015 Jul;296(1):41-9. doi: 10.1016/j.cellimm.2015.04.009. Epub 2015 May 1.

PMID:
25979810
48.

Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity.

Gonnermann D, Oberg HH, Kellner C, Peipp M, Sebens S, Kabelitz D, Wesch D.

Oncoimmunology. 2015 Jan 7;4(3):e988460. eCollection 2015 Mar.

49.

Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.

Ebsen H, Lettau M, Kabelitz D, Janssen O.

Mol Immunol. 2015 Jun;65(2):416-28. doi: 10.1016/j.molimm.2015.02.008. Epub 2015 Mar 5.

PMID:
25745808
50.

Analysis of intestinal microbiota in hybrid house mice reveals evolutionary divergence in a vertebrate hologenome.

Wang J, Kalyan S, Steck N, Turner LM, Harr B, Künzel S, Vallier M, Häsler R, Franke A, Oberg HH, Ibrahim SM, Grassl GA, Kabelitz D, Baines JF.

Nat Commun. 2015 Mar 4;6:6440. doi: 10.1038/ncomms7440.

Supplemental Content

Loading ...
Support Center